To estimate the effects of nobiletin on BPH-associated protein markers, the levels of 5α-reductase, FGF, AR, EGF, Bax, and Bcl-2 were measured in WPMY-1 and BPH-1 cells. The gene discussed is EGF; the disease is benign prostatic hyperplasia.